Clinical Trial

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective platform study that will investigate the outcomes of patients with locoregionally-advanced nasopharyngeal carcinoma (LA-NPC) or recurrent-metastatic nasopharyngeal carcinoma (RM-NPC) who are assigned to treatment arms of different chemotherapy sequencing and intensity based on their pre- and on-treatment plasma EBV DNA results.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-25; most recent amendment 2024-09-05.
Status change: Not Yet Recruiting → Recruiting 2023-04-03
Trial Details
NCT Number NCT05517135
Lead Sponsor National Cancer Centre, Singapore
Conditions Nasopharyngeal Carcinoma
Enrollment 1,000 participants
Start Date 2022-11-17
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-19